Handelsavisen
prelaunch
Companies Basic Materials SPEB.NS
SP
SPEB.NS NSE (India) Specialty Chemicals

Speb.Ns

$73,50
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
14,2 %
ROE
25,4 %
Net margin
11,5 %
Debt / equity
0,00
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

SPEB.NS is a specialty chemicals company that produces and sells chemical products, primarily generating revenue through the sale of these products to industrial and commercial customers.

Business. SPEB.NS is a specialty chemicals company that produces and sells chemical products, primarily generating revenue through the sale of these products to industrial and commercial customers.

Classification92 %
SectorBasic Materials
Business sectorChemicals
IndustrySpecialty Chemicals
ActivityChemicals
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
25,4 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning SPEB.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials · THIS SECTOR+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to SPEB.NS. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    SPEB.NS is a specialty chemicals company that produces and sells chemical products, primarily generating revenue through the sale of these products to industrial and commercial customers.

    Classification92 %
    SectorBasic Materials
    Business sectorChemicals
    IndustrySpecialty Chemicals
    ActivityChemicals
    AI synthesis
    GENERATED

    SPEB.NS maintains a strong capital structure with no long-term debt and a debt-to-equity ratio of 0.0, indicating a fully equity-funded operation. The company's liquidity is reflected in a current ratio of 6.73, suggesting ample short-term assets to cover liabilities. Free cash flow of INR 39.54 million and operating cash flow of INR 39.07 million support operational flexibility and reinvestment opportunities.

    Profitability metrics for SPEB.NS are robust, with a return on equity (ROE) of 25.35% and a return on assets (ROA) of 21.99%. These figures exceed typical benchmarks for the specialty chemicals industry, indicating efficient use of equity and assets to generate returns. The company's operating margin of 14.17% (calculated from operating income of INR 60.40 million on revenue of INR 426.16 million) is also strong, reflecting effective cost management and pricing power.

    Geographic and segment exposure for SPEB.NS is not explicitly detailed in the available data, but the company's revenue concentration is not disclosed. Given the nature of the specialty chemicals industry, it is likely that the company serves a diverse set of industrial customers, though the exact distribution of revenue by region or product line is not available for analysis.

    The company's growth trajectory is supported by a strong cash flow position and no immediate dilution or liquidity risks. While specific revenue growth rates are not provided, the company's operating income and net income suggest a stable and profitable business model. The absence of long-term debt and the presence of positive free cash flow indicate a conservative financial strategy that supports long-term stability.

    Risk factors for SPEB.NS are minimal, with no immediate filing-based liquidity or dilution flags detected. The company's low debt-to-equity ratio and strong liquidity position reduce financial risk. Additionally, the absence of dilution potential and the lack of recent equity issuance suggest that the company is not under pressure to raise capital in the near term. The risk assessment indicates a low probability of dilution, with no near-term pressure expected.

    Recent events for SPEB.NS include the latest financial filing, which provides a snapshot of the company's strong financial position. The company has not issued new shares recently, and there are no indications of upcoming capital-raising activities. The absence of significant regulatory or operational risks in the latest filings supports the view that the company is in a stable and secure financial position.

    Key takeaways
    • SPEB.NS is a specialty chemicals company with a strong capital structure and no long-term debt.
    • The company's profitability metrics, including ROE of 25.35% and ROA of 21.99%, are well above industry benchmarks.
    • SPEB.NS maintains a high current ratio of 6.73, indicating strong liquidity and short-term financial health.
    • The company's financial strategy is conservative, with no immediate dilution or liquidity risks.
    • Recent financial filings confirm a stable and secure financial position with no signs of capital-raising pressure.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $73,50
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $193.0M
    Net cash
    Current ratio
    6.7
    Debt / equity
    0.0
    ROA
    22.0%
    ROE
    25.4%
    Cash conversion
    80.0%
    CapEx / revenue
    -3.3%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin14,2 %Above P75
    Net Margin11,5 %Above P75
    ROE25,4 %Best in class
    Capex / Rev-3,3 %Above median
    D/E0,00Above P75
    Cash Conv0,80Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Return On Assets
      net_income / total_assets
    Source documents
    • SPEB.NS Market data — financials · 2026-05-29

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    SPEB.NSCanonical
    NSE (India) · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage